STAAR Surgical Co
NASDAQ:STAA

Watchlist Manager
STAAR Surgical Co Logo
STAAR Surgical Co
NASDAQ:STAA
Watchlist
Price: 26.68 USD 0.19% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
STAAR Surgical Co?
Write Note

STAAR Surgical Co
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

STAAR Surgical Co
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
STAAR Surgical Co
NASDAQ:STAA
Other Current Liabilities
$25.9m
CAGR 3-Years
22%
CAGR 5-Years
25%
CAGR 10-Years
25%
Haemonetics Corp
NYSE:HAE
Other Current Liabilities
$150m
CAGR 3-Years
8%
CAGR 5-Years
12%
CAGR 10-Years
9%
ICU Medical Inc
NASDAQ:ICUI
Other Current Liabilities
$31.2m
CAGR 3-Years
-3%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Other Current Liabilities
$1.4B
CAGR 3-Years
8%
CAGR 5-Years
21%
CAGR 10-Years
31%
Lantheus Holdings Inc
NASDAQ:LNTH
Other Current Liabilities
$12.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
28%
Merit Medical Systems Inc
NASDAQ:MMSI
Other Current Liabilities
$1.5m
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
-11%
No Stocks Found

STAAR Surgical Co
Glance View

Market Cap
1.3B USD
Industry
Health Care

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is headquartered in Lake Forest, California and currently employs 692 full-time employees. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. The company operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.

STAA Intrinsic Value
22.19 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is STAAR Surgical Co's Other Current Liabilities?
Other Current Liabilities
25.9m USD

Based on the financial report for Sep 27, 2024, STAAR Surgical Co's Other Current Liabilities amounts to 25.9m USD.

What is STAAR Surgical Co's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
25%

Over the last year, the Other Current Liabilities growth was -7%. The average annual Other Current Liabilities growth rates for STAAR Surgical Co have been 22% over the past three years , 25% over the past five years , and 25% over the past ten years .

Back to Top